FDA Investigational New Drug authorisation | 02-Oct-2020 | 07:00 | RNS |
Half-year Report | 24-Sep-2020 | 07:00 | RNS |
License agreement for SlimBiome® Medical in... | 22-Sep-2020 | 07:00 | RNS |
Distributor agreement with Ayalla Marketing | 17-Sep-2020 | 07:00 | RNS |
Second Price Monitoring Extn | 15-Sep-2020 | 11:06 | RNS |
Price Monitoring Extension | 15-Sep-2020 | 11:00 | RNS |
SweetBiotix sweet fibres agreement | 15-Sep-2020 | 07:00 | RNS |
Second Price Monitoring Extn | 03-Sep-2020 | 14:05 | RNS |
Price Monitoring Extension | 03-Sep-2020 | 14:00 | RNS |
Second Price Monitoring Extn | 03-Sep-2020 | 11:05 | RNS |
Price Monitoring Extension | 03-Sep-2020 | 11:00 | RNS |
Scientific and commercial development update | 11-Aug-2020 | 07:00 | RNS |
Extension of terms for OptiBiome with OptiPharm | 05-Aug-2020 | 07:00 | RNS |
Extension of terms for WellBiome with Maxum Foods | 30-Jul-2020 | 07:00 | RNS |
Extension of terms for WellBiome with Agropur | 23-Jul-2020 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 15.10p |
Change Today | -0.15p |
% Change | -0.98 % |
52 Week High | 39.00 |
52 Week Low | 7.35 |
Volume | 13,966 |
Shares Issued | 97.94m |
Market Cap | £14.79m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
09:54 | 13,078 @ 15.26p |
09:26 | 121 @ 15.00p |
09:05 | 761 @ 15.00p |
08:25 | 6 @ 15.50p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research